Catalyst Wire Dossier Catalyst Wire Dossier

EPYSQLI

eculizumab-aagh · Teva Pharmaceuticals USA, Inc.
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for EPYSQLI, covering 2024-07-19 to 2026-08-07. Get the full timeline:

Most recent: EMA Authorised: Epysqli (Eculizumab) — Samsung Bioepis NL B.V.

See pricing